GT Biopharma, Inc. (GTBP) vs Tempest Therapeutics, Inc. (TPST)

• GT Biopharma, Inc. GTBP 4.71 ▼ −2.69%
• Tempest Therapeutics, Inc. TPST 0.38 ▼ −17.39%

GT Biopharma, Inc. and Tempest Therapeutics, Inc. are both Biotechnology companies. GT Biopharma, Inc. is the larger, with a market value of $9.4M against $7.5M — 1.2× the size. Tempest Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; GT Biopharma, Inc. trades at 0.8×. Tempest Therapeutics, Inc. grew revenue faster over the last twelve months: −53.0% against −76.2%. Across the 11 metrics below, GT Biopharma, Inc. leads on 6 and Tempest Therapeutics, Inc. on 5.